David Bumcrot

David Bumcrot" alt="David Bumcrot" itemprop="image">

Company: CAMP4 Therapeutics

Job title: Chief Scientific Officer

Seminars:

Regulating Gene Expression by Targeting Regulatory RNAs: A Novel Therapeutic Approach 11:00 am

Highlighting regRNAs, non-coding transcripts derived from gene regulatory elements, as key regulators of transcription Targeting regRNAs with antisense oligonucleotides (ASO) leads to specific modulation of gene expression Unveiling the potential of ASOs targeting regRNAs have to be a novel class of programmable therapeutics for a range of diseasesRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.